Details for 2016781236

Up to date per 01.04.2026

Actions

Title / Product Name

OPTIMIERTE BISPEZIFISCHE ANTI-CD3-ANTIKÖRPER UND VERWENDUNGEN DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016781236

EP Publication Number

3353212

E-Number

1443910

Language

PCT Number

US16053525

Publication Date

01.08.2018 A

03.11.2021 B1

Registration Date

03.11.2021

AT Publication Date

15.11.2021

Application Date

23.09.2016

Registration Number

Priorities

23.09.2015

201562222605 P

IPC

C07K 16/28 20060101AFI20200819BHEP

Maximum Duration of Protection

23.09.2036

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591-6707US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

SMITH, Eric Tarrytown, New York 10591-6707US

HABER, Lauric Tarrytown, New York 10591-6707US

BABB, Robert Tarrytown, New York 10591-6707US

CHEN, Gang Tarrytown, New York 10591-6707US

MACDONALD, Douglas Tarrytown, New York 10591-6707US

Information about Fees